Adjuvant platinum-based chemotherapy for early stage cervical cancer-Reference-Cited by-同舟云学术

Adjuvant platinum-based chemotherapy for early stage cervical cancer

Published:2016-11-22 Issue:1 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Falcetta Frederico S¹²,Medeiros Lídia RF³,Edelweiss Maria I⁴,Pohlmann Paula R⁵,Stein Airton T⁶,Rosa Daniela D²⁷,Platt Joanne⁸

Affiliation:

1. Oncology; Hospital de Clínicas de Porto Alegre; Porto Alegre Brazil

2. Postgraduation Program in Pathology; Federal University of Health Sciences; Porto Alegre Brazil

3. Social Medicine/Epidemiology; Post-graduation Program in Medical Sciences, Universidade Federal do Rio Grande do Sul; Porto Alegre Brazil

4. Pathology; Faculty of Medicine at Federal University of Rio Grande do Sul; Rio Grande do Sul Brazil

5. Division of Hematology and Oncology; Lombardi Comprehensive Cancer Center; Washington DC USA

6. Department of Public Health; Universidade Federal de Ciências da Saúde; Porto Alegre Brazil

7. Oncology Unit; Hospital Moinhos de Vento; Porto Alegre Brazil

8. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group; Royal United Hospital; Bath UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference110 articles.

1. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix;Liu;Journal of Clinical Oncology,2000

2. Cancer Research UK A prospective randomised trial of adjuvant chemotherapy in node positive early stage carcinoma of the cervix - Protocol CE3005 UK Clinical Trials Register 2001

3. Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy;Sun;BMC Cancer,2015

4. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases;Tattersall;Gynecologic Oncology,1992

5. Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up;Argenta;European Journal of Gynaecological Oncology,2006

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09

2. Novel Hsp90-Targeting PROTACs: Enhanced synergy with cisplatin in combination therapy of cervical cancer;European Journal of Medicinal Chemistry;2024-09

3. Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer;Medical Oncology;2024-07-10

4. Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study;European Journal of Surgical Oncology;2024-04

5. Knockdown of BMI1 Enhances The Sensitivity of Cervical and Endometrial Cancer Cells to Paclitaxe;PROG BIOCHEM BIOPHYS;2024